Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets open weak
Wed, 17 Dec 09:30 am

Asian stock markets have opened on a mixed note with the stock markets in China (up 1.0%) and Malaysia (up 0.8%) leading the gains. However, the stock markets in Taiwan (down 0.6%) and Singapore (down 0.3%) were facing selling pressure. The Indian share markets have opened the day on a weak note as well. Barring software, FMCG and oil and gas, all sectoral indices have opened in the red, with healthcare and consumer durables stocks witnessing maximum selling pressure.

The Sensex today is down by around 83 points (0.3%), while the NSE-Nifty is down by about 25 points (0.3%). The mid cap and small cap stocks too have also opened in red with BSE Mid Cap index and BSE Small Cap index down by around 0.5% and 0.4% respectively. The rupee is currently trading at Rs 63.78 to the US dollar.

Majority of stocks in Indian pharma have opened the day on a weak note with Biocon Ltd and J.B. Chemicals Ltd leading the losses. As per a leading financial daily, Dr. Reddy's Laboratories (DRL) has recently launched Valganciclovir tablets, USP in the strength of 450 mg in the US market and the product has been approved by the United States Food and Drug Administration (USFDA). The tablets are generic version of Roche's Valcyte tablets. As per IMS health, the latter had US sales of approximately US$ 440 m MAT for the most recent twelve months ending in October 2014.

As per a leading financial daily, the government has recently raised import tariff value on gold to US$396 per 10 grams and on silver to US$561 per kg in line with volatile global price trends. Globally, gold and silver prices have been volatile in the last few weeks. In London, gold prices rose today 0.53 % to US$1,199.80 per ounce, while silver also increased to US$16.22 per ounce. However, the gold prices showed a decline in the domestic market. Gold was sold at Rs 27,200 per 10 grams and silver at Rs 37,050 per kg in the national capital. It is noteworthy here that the import tariff value is the base price at which customs duty is determined to prevent under-invoicing. It is revised on a fortnightly basis taking into account global prices.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets open weak". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.